Atria Investments Inc reduced its position in Transcat, Inc. (NASDAQ:TRNS – Free Report) by 27.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,852 shares of the scientific and technical instruments company’s stock after selling 707 shares during the period. Atria Investments Inc’s holdings in Transcat were worth $224,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. DekaBank Deutsche Girozentrale acquired a new position in Transcat during the second quarter valued at approximately $40,000. nVerses Capital LLC bought a new position in Transcat in the 3rd quarter worth $60,000. First Horizon Advisors Inc. raised its holdings in Transcat by 26.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock worth $72,000 after acquiring an additional 125 shares during the period. Fifth Third Bancorp boosted its holdings in Transcat by 95.8% during the second quarter. Fifth Third Bancorp now owns 656 shares of the scientific and technical instruments company’s stock valued at $79,000 after acquiring an additional 321 shares during the period. Finally, Quest Partners LLC acquired a new stake in shares of Transcat in the second quarter valued at about $109,000. 98.34% of the stock is owned by hedge funds and other institutional investors.
Transcat Trading Up 2.1 %
Shares of NASDAQ TRNS opened at $109.02 on Friday. The firm has a market capitalization of $1.00 billion, a price-to-earnings ratio of 55.06 and a beta of 0.69. Transcat, Inc. has a one year low of $94.29 and a one year high of $147.12. The business has a fifty day simple moving average of $116.61 and a 200 day simple moving average of $121.50.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on TRNS shares. Oppenheimer restated an “outperform” rating and set a $130.00 target price (down previously from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. Craig Hallum reduced their price objective on Transcat from $138.00 to $113.00 and set a “buy” rating for the company in a research report on Wednesday, October 30th. StockNews.com lowered shares of Transcat from a “hold” rating to a “sell” rating in a research report on Tuesday, October 29th. Northland Securities reduced their price target on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a report on Wednesday, October 30th. Finally, HC Wainwright restated a “buy” rating and issued a $156.00 price target on shares of Transcat in a research report on Tuesday, October 29th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $127.25.
Get Our Latest Analysis on TRNS
About Transcat
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Recommended Stories
- Five stocks we like better than Transcat
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- How to Buy Cheap Stocks Step by Step
- MarketBeat Week in Review – 11/18 – 11/22
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS – Free Report).
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.